{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:54:20Z","timestamp":1789908860576,"version":"4.0.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s137588","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T17:42:17Z","timestamp":1560793337000},"page":"1993-2000","source":"Crossref","is-referenced-by-count":14,"title":["<p>Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis<\/p>"],"prefix":"10.2147","volume":"Volume 13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3763-3309","authenticated-orcid":true,"given":"Eric J","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1225-8944","authenticated-orcid":true,"given":"Mary Patricia","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3544-896X","authenticated-orcid":true,"given":"Karen","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Bhutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,6]]},"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=50564","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=50564","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T17:42:19Z","timestamp":1560793339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/evaluating-guselkumab-an-anti-il-23-antibody-for-the-treatment-of-plaq-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/dddt.s137588","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}